176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.06%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-2.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2.78%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-5.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-5.26%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-5.68%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.37%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.67%
Diluted share change of 0.67% while INTC is zero. Bruce Berkowitz might see a minor difference that could widen over time.
2.02%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
-39.53%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-48.79%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
86.02%
10Y revenue/share CAGR at 75-90% of INTC's 104.45%. Bill Ackman would press for new markets or product lines to narrow the gap.
50.25%
5Y revenue/share CAGR above 1.5x INTC's 21.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
57.02%
3Y revenue/share CAGR above 1.5x INTC's 22.08%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
495.91%
10Y OCF/share CAGR above 1.5x INTC's 207.21%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
98.76%
5Y OCF/share CAGR above 1.5x INTC's 38.82%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
102.08%
3Y OCF/share CAGR above 1.5x INTC's 17.26%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
110.08%
Similar net income/share CAGR to INTC's 121.60%. Walter Schloss would see parallel tailwinds or expansions for both firms.
60.55%
5Y net income/share CAGR above 1.5x INTC's 14.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
189.06%
3Y net income/share CAGR above 1.5x INTC's 60.32%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
153.51%
10Y equity/share CAGR 1.25-1.5x INTC's 117.88%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
34.80%
5Y equity/share CAGR at 50-75% of INTC's 51.30%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-0.08%
Negative 3Y equity/share growth while INTC is at 21.26%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.94%
3Y dividend/share CAGR above 1.5x INTC's 15.67%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
3.56%
AR growth well above INTC's 4.93%. Michael Burry fears inflated revenue or higher default risk in the near future.
-5.74%
Inventory is declining while INTC stands at 4.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.55%
Negative asset growth while INTC invests at 2.05%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.76%
We have a declining book value while INTC shows 1.19%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.07%
We’re deleveraging while INTC stands at 1.85%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.58%
R&D dropping or stable vs. INTC's 1.40%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.